Publications

Ex-vivo models of post-surgical residual disease in human glioblastoma

Rominiyi Ola, McGarrity-Cottrell Connor, Myers Katie, Jones Callum, Wosnitzka Kelsey, Williams Sophie T, Vanderlinden Aurelie, Antohj Andra-Gabriela, Gomez-Roman Natividad, Chalmers Anthony J, Sinha Saurab, Carrol Thomas A, Wang Dennis, Cavalli Andrea, Bagga Veejay, Al-Tamimi Yahia, Dunning Mark J, Collis Spencer J

F1000Research Vol 13 (2024)

https://doi.org/10.12688/f1000research.157013.1

P13.06. A evaluation of BBB permeable WEE1 and CHK1 inhibitors in combination with standard of care for the treatment of Glioblastoma

Scholefield E L, Gomez-Roman N

Neuro-Oncology Vol 26, pp. v72-v72 (2024)

https://doi.org/10.1093/neuonc/noae144.239

ClonoScreen3D – a novel three-dimensional clonogenic screening platform for identification of radiosensitizers for glioblastoma

Jackson Mark R, Richards Amanda R, Ayoola Oladipupo Abdul-Basit, Chahal Sandeep K, Carager Seamus, Chalmers Anthony J, Gomez-Roman Natividad

International Journal of Radiation Oncology - Biology - Physics Vol 120, pp. 162-177 (2024)

https://doi.org/10.1016/j.ijrobp.2024.02.046

A joint physics and radiobiology DREAM team vision - towards better response prediction models to advance radiotherapy

Vens C, van Luijk P, Vogelius RI, El Naqa I, Humbert-Vidan L, von Neubeck C, Gomez-Roman N, Bahn E, Brualla L, Böhlen TT, Ecker S, Koch R, Handeland A, Pereira S, Possenti L, Rancati T, Todor D, Vanderstraeten B, Van Heerden M, Ullrich W, Jackson M, Alber M, Marignol L

Radiotherapy and Oncology Vol 196 (2024)

https://doi.org/10.1016/j.radonc.2024.110277

ClonoScreen3D : a novel three-dimensional clonogenic screening platform for identification of radiosensitizers for glioblastoma

Jackson Mark R, R Richards Amanda, Ayoola Oladipupo Abdul-Basit, Chahal Sandeep K, Carager Seamus, Chalmers Anthony J, Gomez-Roman Natividad

(2023)

https://doi.org/10.1101/2023.10.04.560635

Evaluating the enhancement of cell kill by radiation therapy through novel wee1 inhibitors with improved brain permeability in the treatment of glioblastoma

Scholefield Emma, Gomez-Roman Natividad

Cancer Research UK - Association for Radiation Research Conference (2023)

More publications

Professional Activities

Targeting cholesterol metabolism to overcome radiation resistance in glioblastoma

Speaker

19/10/2024

VIVA (PhD) - internal examiner

Examiner

23/5/2024

European Society for Radiotherapy and Oncology

Participant

3/5/2024

How does radiation affect cell metabolism?

Speaker

3/5/2024

Molecular Oncology (Journal)

Peer reviewer

12/12/2023

Expanding Theories call

Advisor

10/12/2023

More professional activities

Projects

Investigating neurotransmitter-mediated tumour microenvironment in glioblastoma

Li, Jianbin (Post Grad Student) Gomez-Roman, Natividad (Principal Investigator)

01-Jan-2024 - 30-Jan-2027

Exploring nanoscale mechanical stimulation as a novel therapeutic avenue for hard-to-treat brain cancers

Gomez-Roman, Natividad (Principal Investigator)

01-Jan-2024 - 30-Jan-2025

Characterising cholesterol trafficking in glioblastoma and brain cells, and its contribution to tumour development, progression and treatment resistance

Gomez-Roman, Natividad (Principal Investigator)

01-Jan-2024 - 31-Jan-2027

Development of A Novel Non-Animal Research Method for Glioblastoma Research

Gomez-Roman, Natividad (Principal Investigator)

22-Jan-2024 - 30-Jan-2024

Exploring Cholesterol Metabolism, Lipid Droplets, and NPC Dysfunction in Cellular Health and Disease

Gomez-Roman, Natividad (Principal Investigator) Hutchison, Amber (Researcher)

The project aims to address the connection between cholesterol metabolism, lipid droplets and
NPC dysfunction in glioblastoma cells to uncover a novel therapeutic intervention that exploits lipid metabolism in cancer cells

10-Jan-2024 - 12-Jan-2024

Exploring the Reversed Blood-Brain Barrier

Witte, Kimia (Principal Investigator) Gomez-Roman, Natividad (Co-investigator)

01-Jan-2023 - 31-Jan-2024

More projects